Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
20.6 USD | +2.03% | +6.73% | -25.08% |
15/04 | Goldman Sachs Cuts Veracyte Price Target to $28 From $32, Maintains Buy Rating | MT |
26/02 | Morgan Stanley Trims Veracyte's Price Target to $21 From $22, Keeps Underweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.08% | 1.54B | |
-16.50% | 11.13B | |
+65.38% | 3.6B | |
-29.61% | 2.26B | |
-14.31% | 2.16B | |
+37.25% | 1.17B | |
-3.28% | 744M | |
-38.16% | 432M | |
+21.07% | 357M | |
+15.53% | 225M |
- Stock Market
- Equities
- VCYT Stock
- News Veracyte, Inc.
- SVB Securities Adjusts Veracyte's Price Target to $35 From $30, Keeps Outperform Rating